• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨巨细胞瘤:214例患者的治疗与预后

Giant cell tumor of bone: treatment and outcome of 214 cases.

作者信息

Balke Maurice, Schremper Laura, Gebert Carsten, Ahrens Helmut, Streitbuerger Arne, Koehler Gabriele, Hardes Jendrik, Gosheger Georg

机构信息

Department of Orthopedic Surgery, University of Muenster, Muenster, Germany.

出版信息

J Cancer Res Clin Oncol. 2008 Sep;134(9):969-78. doi: 10.1007/s00432-008-0370-x. Epub 2008 Mar 6.

DOI:10.1007/s00432-008-0370-x
PMID:18322700
Abstract

BACKGROUND

Two hundred and fourteen patients with benign giant cell tumor of bone (GCTB), treated from 1980 to 2007 at the Department of Orthopedics of the University of Muenster (Germany), were analyzed in a retrospective study.

PATIENTS AND METHODS

The mean age was 33.3 years with a female-to-male ratio of 1.2 : 1. The mean follow up was 59.8 months. The recurrence rate of patients who received first treatment at our institution was 16.6%. The most common primary treatment was curettage (188 patients) usually followed by adjuvant local therapy. The effects of bone cement (PMMA), burring and hydrogen peroxide (H(2)O(2)) were statistically analyzed and the influence of a subchondral bone graft on the recurrence rate was evaluated.

RESULTS

PMMA alone (n = 52) reduces the likelihood of recurrence by the factor 8.2, additional high-speed burring (n = 39) by the factor 3.9 (compared to PMMA only). H(2)O(2) (n = 42) seems to have an additional effect comparable to that of phenol although it did not reach statistical significance.

CONCLUSION

The combination of all adjuncts (PMMA, burring, H(2)O(2) - n = 42) reduces the likelihood of recurrence by the factor 28.2 compared to curettage only and therefore should be recommended as a standard treatment. If the tumor reaches close to the articulating surface a subchondral bone graft (n = 42) can be performed without risking a higher recurrence rate. We add seven cases of pulmonary metastases and two cases of multicentricity to the literature. Bisphosphonates and interferon alpha may have a beneficial effect.

摘要

背景

对1980年至2007年在德国明斯特大学骨科接受治疗的214例骨巨细胞瘤(GCTB)患者进行了一项回顾性研究。

患者与方法

平均年龄为33.3岁,女性与男性比例为1.2∶1。平均随访时间为59.8个月。在我们机构接受首次治疗的患者复发率为16.6%。最常见的主要治疗方法是刮除术(188例患者),通常随后进行辅助局部治疗。对骨水泥(PMMA)、高速磨钻和过氧化氢(H₂O₂)的效果进行了统计学分析,并评估了软骨下骨移植对复发率的影响。

结果

单独使用PMMA(n = 52)可使复发可能性降低8.2倍,额外进行高速磨钻(n = 39)可使复发可能性降低3.9倍(与仅使用PMMA相比)。H₂O₂(n = 42)似乎具有与苯酚相当的额外效果,尽管未达到统计学显著性。

结论

与仅进行刮除术相比,所有辅助治疗方法联合使用(PMMA、高速磨钻、H₂O₂ - n = 42)可使复发可能性降低28.2倍,因此应推荐作为标准治疗方法。如果肿瘤接近关节面,可进行软骨下骨移植(n = 42)而不会增加更高的复发风险。我们在文献中增加了7例肺转移和2例多中心性病例。双膦酸盐和α干扰素可能具有有益作用。

相似文献

1
Giant cell tumor of bone: treatment and outcome of 214 cases.骨巨细胞瘤:214例患者的治疗与预后
J Cancer Res Clin Oncol. 2008 Sep;134(9):969-78. doi: 10.1007/s00432-008-0370-x. Epub 2008 Mar 6.
2
Treatment options for recurrent giant cell tumors of bone.复发性骨巨细胞瘤的治疗选择
J Cancer Res Clin Oncol. 2009 Jan;135(1):149-58. doi: 10.1007/s00432-008-0427-x. Epub 2008 Jun 3.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
5
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.
6
Giant cell tumours of the small bones of the hands and feet: long-term results of 30 patients and a systematic literature review.手部和足部小骨的巨细胞瘤:30 例患者的长期结果和系统文献回顾。
Bone Joint J. 2013 Jun;95-B(6):838-45. doi: 10.1302/0301-620X.95B6.30876.
7
Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?从后方软组织肿块中解剖和保留粘连的腘血管是否会增加股骨远端骨肉瘤患者局部复发的比例?
Clin Orthop Relat Res. 2023 Nov 1;481(11):2167-2176. doi: 10.1097/CORR.0000000000002775. Epub 2023 Aug 1.
8
Are Vascularized Fibula Autografts a Long-lasting Reconstruction After Intercalary Resection of the Humerus for Primary Bone Tumors?带血管腓骨自体移植在肱骨骨干原发性骨肿瘤切除后作为一种长期重建方法的效果如何?
Clin Orthop Relat Res. 2023 Nov 1;481(11):2185-2197. doi: 10.1097/CORR.0000000000002739. Epub 2023 Jun 26.
9
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
10
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.

引用本文的文献

1
Radical resection of a giant cell tumor of the distal ulna and reconstruction with a 3D-printed distal ulnar prosthesis: A case report.尺骨远端巨细胞瘤根治性切除并3D打印尺骨远端假体重建:一例报告
Medicine (Baltimore). 2025 Jul 18;104(29):e43504. doi: 10.1097/MD.0000000000043504.
2
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB11-C1 and NCC-GCTB12-C1.两种源自骨巨细胞瘤的新型患者来源细胞系的建立与鉴定:NCC-GCTB11-C1和NCC-GCTB12-C1。
Hum Cell. 2025 Jul 12;38(5):128. doi: 10.1007/s13577-025-01254-3.
3
Giant Cell Tumor of the Proximal Femur with Pathological Fracture of Femoral neck.

本文引用的文献

1
Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.骨巨细胞瘤患者再次手术会导致膝关节骨关节炎改变。
Knee. 2007 Oct;14(5):369-74. doi: 10.1016/j.knee.2007.05.008. Epub 2007 Jun 29.
2
Giant cell tumour of bone: morphological, biological and histogenetical aspects.骨巨细胞瘤:形态学、生物学及组织发生学方面
Int Orthop. 2006 Dec;30(6):484-9. doi: 10.1007/s00264-006-0215-7. Epub 2006 Sep 30.
3
Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results.
股骨近端骨巨细胞瘤合并股骨颈病理性骨折
J Orthop Case Rep. 2025 Jun;15(6):113-118. doi: 10.13107/jocr.2025.v15.i06.5684.
4
Pulmonary metastasis of giant cell tumor of bone 29 years after local recurrence resection: implications for Long-Term surveillance.骨巨细胞瘤局部复发切除29年后出现肺转移:对长期监测的启示
Discov Oncol. 2025 Jun 15;16(1):1108. doi: 10.1007/s12672-025-02880-x.
5
Giant cell tumor of the thoracic spine: An unusual cause for spinal cord compression.胸椎骨巨细胞瘤:脊髓压迫的罕见病因。
Radiol Case Rep. 2025 Apr 19;20(7):3372-3375. doi: 10.1016/j.radcr.2025.03.055. eCollection 2025 Jul.
6
Total resection of sacral giant cell tumor with en bloc resection, sacral nerve reconstruction, and custom 3D-printed implant: a case report with long-term follow-up.采用整块切除、骶神经重建及定制3D打印植入物技术对骶骨巨细胞瘤进行全切除:1例长期随访病例报告
Int J Surg Case Rep. 2025 May;130:111293. doi: 10.1016/j.ijscr.2025.111293. Epub 2025 Apr 12.
7
Denosumab regimens in the treatment of giant cell tumor of bone: A systematic review with meta-analysis.地诺单抗治疗骨巨细胞瘤的方案:一项荟萃分析的系统评价
World J Orthop. 2025 Mar 18;16(3):102520. doi: 10.5312/wjo.v16.i3.102520.
8
Management and surveillance of metastatic giant cell tumour of bone.骨转移性巨细胞瘤的管理与监测
Pathol Oncol Res. 2025 Feb 19;31:1611916. doi: 10.3389/pore.2025.1611916. eCollection 2025.
9
Comparative analysis of aggressiveness in giant cell tumor of bone between upper and lower extremities: A systematic review and meta-analysis.骨巨细胞瘤上下肢侵袭性的比较分析:一项系统评价和荟萃分析。
J Bone Oncol. 2025 Feb 8;51:100663. doi: 10.1016/j.jbo.2025.100663. eCollection 2025 Apr.
10
En-bloc resection for spinal giant cell tumors: superior outcomes-a comprehensive meta-analysis and trial sequential analysis.脊柱巨细胞瘤的整块切除:卓越疗效——一项全面的荟萃分析和序贯试验分析
Neurosurg Rev. 2025 Feb 13;48(1):230. doi: 10.1007/s10143-025-03342-2.
骨水泥固定或植骨技术治疗骨巨细胞瘤患者负重关节退变改变的比较:中期结果
Int Orthop. 2006 Dec;30(6):505-9. doi: 10.1007/s00264-006-0190-z. Epub 2006 Sep 13.
4
Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases.骨多中心巨细胞瘤。30例临床病理分析。
J Bone Joint Surg Am. 2006 Sep;88(9):1998-2008. doi: 10.2106/JBJS.E.01111.
5
Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution.组织学证实的良性巨细胞瘤肺转移——来自单一机构的14例病例
Int Orthop. 2006 Dec;30(6):499-504. doi: 10.1007/s00264-006-0204-x. Epub 2006 Aug 15.
6
Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy.采用刮除、磨钻和植骨术在不进行辅助治疗的情况下对长骨巨细胞瘤进行局部控制。
Int Orthop. 2006 Dec;30(6):495-8. doi: 10.1007/s00264-006-0146-3. Epub 2006 Aug 2.
7
Ethanol as a local adjuvant for giant cell tumor of bone.乙醇作为骨巨细胞瘤的局部佐剂。
Iowa Orthop J. 2006;26:69-76.
8
[Giant cell tumor at the wrist: a review of 23 cases].[腕部巨细胞瘤:23例病例回顾]
Acta Orthop Traumatol Turc. 2006;40(2):144-50.
9
Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study.刮除及骨水泥填充术后长骨巨细胞瘤局部复发的治疗。一项斯堪的纳维亚肉瘤研究组的研究。
J Bone Joint Surg Br. 2006 Apr;88(4):531-5. doi: 10.1302/0301-620X.88B4.17407.
10
Multiple skeletal metastases from a giant cell tumour of the distal fibula with fatal outcome.来自腓骨远端巨细胞瘤的多发性骨转移,预后致命。
J Bone Joint Surg Br. 2006 Mar;88(3):396-9. doi: 10.1302/0301-620X.88B3.16606.